Aflibercept-related sterile inflammation

Ophthalmology

Volumn 120, Issue 5, 2013, Pages

  Hahn, Paul ^a   Kim, Judy E ^b   Stinnett, Sandra ^a   Chung, Mina M ^c   Dugel, Pravin U ^d   Flynn, Harry W ^e   Huang, Suber S ^f   Sadda, Srinivas R ^g   Mahmoud, Tamer H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d RETINAL CONSULTANTS OF ARIZONA   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; ANTIBIOTIC AGENT; STEROID;

ANTIBIOTIC THERAPY; CLINICAL ARTICLE; DRUG INDICATION; DRUG SURVEILLANCE PROGRAM; EYE INFLAMMATION; EYE PAIN; EYE REDNESS; HUMAN; NOTE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; TOPICAL TREATMENT; UVEITIS; VISUAL ACUITY; VITRECTOMY;

EID: 84877750900     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.11.018     Document Type: Letter

References (3)

1. M. Taban, R.P. Singh, J.Y. Chung Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis Am J Ophthalmol 144 2007 50 54
2. C.N. Kay, R.M. Tarantola, K.M. Gehrs Uveitis following intravitreal bevacizumab: a non-infectious cluster Ophthalmic Surg Lasers Imaging 42 2011 292 296
3. M. Georgopoulos, K. Polak, F. Prager Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin) Br J Ophthalmol 93 2009 457 462